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Anti-corruption, transparency and accountability mea-
sures are often missing from efforts to promote universal
health coverage. Yet, if unchecked, corruption represents
a significant drain on domestic health resources and
a major barrier to achieving universal health coverage
and the sustainable development goals. The World
Health Organization (WHO) is promoting
a coordinated public health approach to anti-corruption,
transparency and accountability, working with global
partners to create new internal control and assurance
models; increase monitoring and evaluation; develop
capacity for multiple stakeholders to address corruption;
and strengthen normative guidance to integrate anti-
corruption, transparency and accountability into
WHO’s work on health systems strengthening. The arti-
cles in this special issue explore evidence on the impact of
corruption on health, human rights approaches to con-
trol corruption, corruption in human resources, tools for
addressing corruption in the pharmaceutical sector, and
solutions to improve transparency and accountability.
New approaches to risk assessment are also proposed.
Moving forward, this issue represents a call for action to
combat health system corruption through targeted
research, informed strategies, and effective cross-sectoral
interventions. Taking steps nowwill allow all countries to
seize the pledge of leaving no one behind in addressing
inequalities and achieving health for all.
Universal health coverage (UHC) is an objective
towards which all countries strive. UHC means that all
individuals and communities receive the health services
they need without suffering financial hardship. Work
toward UHC focuses on health system strengthening
efforts, policies, and programs that aim to address gaps
in financing, service delivery and improve access to health
workers, medicines and vaccines. Anti-corruption, trans-
parency and accountability (ACTA) measures are often
neglected in these efforts, a critical omission because if
unchecked, corruption in health systems represents
a significant drain on domestic health resources and
poses a major barrier to efforts to the attainment of
UHC and other health-related Sustainable Development
Goal (SDG) targets. WHO therefore regards ACTA
measures as central components of health systems
strengthening for UHC and actively supports member
states’ ACTA efforts as part of its general program of
work.
WHO prioritizes work on ACTA because ACTA
measures are essential for upholding the right to health
and other indivisible rights which are at the heart of
WHO’s mandate. Without ACTA measures, resources
meant to deliver on health goals may be wasted, trust in
the health system is weakened, and, most importantly,
human lives can be lost. Researchers estimate that 1.6%of
the world deaths in children, or 140,000 child deaths
per year, could be indirectly attributed to corruption
[1]. Because corruption in the health sector has
a disproportionate effect on disadvantaged populations,
and is amajor driver of health inequities,WHOconsiders
that ACTA measures are essential for ensuring that ‘no
one is to be left behind’ on the road towards UHC.
WHO is a health agency and so takes a public health
approach to ACTA, an approach that seeks to support
efforts towards UHC by identifying and addressing the
underlying risk factors that increase the likelihood of
health system corruption and create barriers to UHC.
This is quite a different approach to traditional
approaches to addressing corruption that have focused
on prohibition, criminalization and punitive approaches.
By taking a public health preventive approach to addres-
sing the entry points where corruption could occur,
much can be done to produce a paradigm shift in how
health systems, as well as development partners, address
ACTA. All societies and country contexts are vulnerable
to corruption; acknowledging this, proactively building
institutional capacity and ensuring measures to inhibit/
prevent the development of corruption is an important
part of wider reforms towards UHC. It enables the max-
imization of health benefits from public resources and
builds public trust in the system. While punitive/reme-
dial actions are often still required, an increased focus on
prevention shifts the dominant focus from reactive mea-
sures towards creating innovations in prevention, includ-
ing risk management, and opening new venues for
addressing what is politically sensitive issue.
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Health system corruption is a global public
health problem and requires a global public health
approach to solve it. To date, there has been an
absence of a coordinated and coherent approach
to ACTA amongst stakeholders working in global
health, as well as between those working on ACTA
at cross-sectoral levels and the health community
both globally and domestically. This has limited
the potential contribution of ACTA work to UHC.
To respond to this challenge, work is underway to
initiate a ‘Global network on ACTA in the health
sector’. On 26–28 February 2019, a consultation
was jointly convened by WHO, Global Fund and
UNDP (with co-funding from UK Aid), with more
than 130 global stakeholders focused on the goal
of informing the workplan of this network. The
consultation provided content for core network
workstreams during the 2020–2023 period:
(1) Rationalizing internal control and assurance
models in health systems using fraud and cor-
ruption risk assessment methodologies;
(2) Monitoring and evaluation of ACTA measures
for health;
(3) Capacity development on ACTA in the health
sector for multiple stakeholders; and,
(4) Integration of ACTA into health systems
strengthening normative guidance.
The work of this network and the importance of
ACTA to efforts towards UHC was highlighted at
the UN High Level meeting on UHC in New York
on 23 September 2019. This special issue provides
a timely input to further discussions about the
importance of ACTA started at the United
Nations and makes a major contribution to
WHO’s work on ACTA and to the four work-
streams that are being developed for the global
ACTA network. Specifically, this special issue con-
tributes to all these efforts across five thematic
areas:
ACTA frameworks
The critical review by Vian [2] summarizes evidence
on anti-corruption, transparency and accountability
concepts, frameworks, and approaches. Vian identi-
fies six typologies and frameworks which model rela-
tionships among factors influencing corruption,
including transparency, accountability, and civic par-
ticipation. Her article also identifies important
approaches to anti-corruption, focused on strategies
such as risk assessment, transparency interventions,
audit, and systems-level reforms.
ACTA and human rights
Sharifah Sekalala and co-authors examine corruption
through a human rights lens [3]. They examine how
human rights mechanisms can facilitate accountabil-
ity for health services, thereby reducing the impact of
corruption on the right to health. They discuss the
empowerment of civil society actors, and how facil-
itating community representation in health policy
and programmatic decision-making can help address
corruption.
ACTA and the health workforce
The review by Monica Kirya examines how corrup-
tion affects the recruitment and promotion of health
workers and how this in turn affects access, quality
and health outcomes [4]. Kirya analyzes global evi-
dence related to six types of corrupt practices in
recruitment and promotion, including patronage
and clientelism, nepotism, cronyism, bribery, extor-
tion and sextortion (a practice where sex, not money,
is the currency of extortion or bribery). Kirya dis-
cusses how support is needed to help countries design
and implement merit-based recruitment systems for
human resources for health. This will not only ensure
that properly qualified and skilled health workers
attend to patients, but it is also as a means to curb
other types of corruption in the health sector.
Corruption and procurement
Kohler and Dimancesco argue for the importance of
integrating ACTA measures into governance for phar-
maceuticals procurement [5]. Their article provides
a primer on key factors, types, and examples of corrup-
tion in pharmaceutical procurement. It examines in
deeper detail the overarching role of good governance
in pharmaceuticals, and specific anti-corruption tools
such as integrity pacts, price transparency, open con-
tracting, and e-procurement. Tim Mackey and Raphael
Cuomo analyze evidence from the medical, engineer-
ing, and computer science literature to determine what
we know about digital solutions to improve transpar-
ency and accountability in medicines procurement and
supply [6]. They focus in particular on e-procurement
systems,machine learning approaches, and other digital
solutions allowing the detection of fraud and abuse.
Arguing for a paradigm shift in
anti-corruption efforts
Hunter et al. describe how the UNDP developed and
tested a new approach to ACTA in the health sector in
the Arab Countires (this is a UNDP classification for
describing the region. WHO has a different classification
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and calls it the Eastern Mediterranean Region). This can
provide an entry point for broader good governance
reforms [7]. The authors note that national ACTA stra-
tegies have included legal frameworks, anti-corruption
agencies, investigation and ensuing enforcement, and
awareness-raising. While such strategies promote integ-
rity, they argue that they provide insufficient guidance for
control of corruption at the sectoral level, and are insen-
sitive to context. Wierzynska and co-authors provide
another perspective on how the international community
engages in ACTA in the health sector [8]. Building on the
UNDP work, the authors propose a paradigm shift from
compliance to risk management centered on events that
could be most harmful to health services and outcomes.
Applying this Fraud Risk Assessment methodology, the
new anti-corruption formula can help identify risks in
a wide set of activities, from petty to grand, involving
functions such as financing, supervision, service delivery,
and data collection. Their article describes the steps to
apply this method.
A call to action for sustained ACTA efforts
Moving forward, this special issue supports a call for
action for sustained efforts to combat health system
corruption and to support the efforts of the global net-
work on ACTA. Much more needs to be done to
address health system corruption if we are to achieve
UHC. More research is required about the magnitude,
scope, characteristics and consequences of corruption.
Much is still hidden and unexplored. We also need
research to better diagnose the causes of health system
corruption, the factors that increase or decrease the risk
of corruption, and the factors that can be modified to
reduce corruption risk through health systems strength-
ening interventions. Finally, we need to share ACTA
success stories, especially how to implement effective
and promising ACTA interventions in a wide range of
health settings. This will allow all countries to seize the
SDG pledge of leaving no one behind by integrating
ACTA into the development and health agendas allow-
ing for an increase in health system efficiencies and
effectiveness and addressing inequalities that drive
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